Specify a stock or a cryptocurrency in the search bar to get a summary
BB Biotech AG
BBZABB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland. Address: Seestrasse 16, Küsnacht, Switzerland, CH-8700
Analytics
WallStreet Target Price
40.1 CHFP/E ratio
17.2489Dividend Yield
5.31 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BBZA
Dividend Analytics BBZA
Dividend growth over 5 years
-14 %Continuous growth
–Payout Ratio 5 years average
-15 %Dividend History BBZA
Stock Valuation BBZA
Financials BBZA
Results | 2019 | Dynamics |